Perrigo (NYSE:PRGO) was the target of unusually large options trading activity on Monday. Traders purchased 3,137 put options on the stock. This represents an increase of approximately 764% compared to the average volume of 363 put options.
In other news, CEO Uwe Roehrhoff purchased 7,500 shares of Perrigo stock in a transaction that occurred on Monday, March 5th. The shares were acquired at an average price of $81.85 per share, for a total transaction of $613,875.00. Following the transaction, the chief executive officer now owns 4,900 shares of the company’s stock, valued at approximately $401,065. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 6.90% of the company’s stock.
Get Perrigo alerts:
Hedge funds have recently added to or reduced their stakes in the company. Dupont Capital Management Corp bought a new position in shares of Perrigo during the fourth quarter valued at $104,000. Twin Tree Management LP raised its stake in shares of Perrigo by 271.0% during the first quarter. Twin Tree Management LP now owns 2,223 shares of the company’s stock valued at $185,000 after acquiring an additional 3,523 shares during the last quarter. ARP Americas LP bought a new position in shares of Perrigo during the fourth quarter valued at $212,000. Quantitative Systematic Strategies LLC bought a new position in shares of Perrigo during the fourth quarter valued at $213,000. Finally, Investors Research Corp bought a new position in shares of Perrigo during the fourth quarter valued at $214,000. 79.52% of the stock is owned by hedge funds and other institutional investors.
PRGO has been the topic of several analyst reports. Canaccord Genuity set a $105.00 price target on shares of Perrigo and gave the stock a “buy” rating in a research report on Monday, April 16th. Cantor Fitzgerald set a $107.00 price target on shares of Perrigo and gave the stock a “buy” rating in a research report on Tuesday, May 8th. Wells Fargo set a $84.00 price target on shares of Perrigo and gave the stock a “market perform” rating in a research report on Monday. Berenberg Bank initiated coverage on shares of Perrigo in a research report on Thursday, February 1st. They set a “buy” rating and a $117.00 price target on the stock. Finally, JPMorgan Chase reiterated a “neutral” rating and set a $83.00 price target (up previously from $82.00) on shares of Perrigo in a research report on Monday, March 5th. Two research analysts have rated the stock with a sell rating, eight have given a hold rating and nine have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $93.06.
Shares of Perrigo opened at $74.94 on Tuesday, MarketBeat.com reports. Perrigo has a fifty-two week low of $71.37 and a fifty-two week high of $75.36. The company has a current ratio of 2.08, a quick ratio of 1.48 and a debt-to-equity ratio of 0.53. The company has a market capitalization of $10.73 billion, a price-to-earnings ratio of 15.05, a P/E/G ratio of 1.91 and a beta of 0.77.
Perrigo (NYSE:PRGO) last issued its earnings results on Tuesday, May 8th. The company reported $1.26 earnings per share for the quarter, beating analysts’ consensus estimates of $1.14 by $0.12. Perrigo had a net margin of 2.59% and a return on equity of 11.93%. The firm had revenue of $1.22 billion for the quarter, compared to analyst estimates of $1.21 billion. During the same quarter last year, the business posted $1.05 earnings per share. The company’s quarterly revenue was up 1.9% on a year-over-year basis. equities analysts anticipate that Perrigo will post 5.27 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 19th. Shareholders of record on Friday, June 1st will be given a $0.19 dividend. The ex-dividend date of this dividend is Thursday, May 31st. This represents a $0.76 dividend on an annualized basis and a yield of 1.01%. Perrigo’s dividend payout ratio is currently 15.42%.
Perrigo Company Profile
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.